Evolving hypotheses on the mechanisms underlying ACS
Peter Libby considers how the pathophysiology of atherosclerosis and the mechanisms of ACS are changing, as a result of preventive therapies and a change in risk factors, toward superficial erosion.
Educational information
Vascular Biology Working Group Meeting at ACC 2016, Chicago, IL, USA
Disclosures
Peter Libby, MD - Mallinckrodt Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
Share this page with your colleagues and friends: